Comvita Limited — Director's Dealing 2021

Aug 31, 2021

DocuSign Envelope ID: DA8D0AFF-6DBD-4321-B70D-7CC034A1B4C3

==> picture [80 x 22] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ToNZX Limited; and
Name of listed issuer:		Comvita Limited
Date this disclosure made:		1-Sep-21
Date of last disclosure:		24-May-21
Director or senior managergiving disclosure
Full name(s):		David Robert Banfield
Name of listed issuer:		Comvita Limited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		CEO
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:		Ordinary sharesPerformance share rights
Nature of the affected relevant interest(s):		Registered Holder
For that relevant interest-
		505,230 ordinary shares (167,742 held by David
Number held in class before acquisition or disposal:		Banfield and 337,488 held on behalf of the Davidand Joy Banfield Trust)
		35,494performance share rights
		521,561 ordinary shares (184,073 held by David
Number held in class after acquisition or disposal:		Banfield and 337,488 held on behalf of the Davidand Joy Banfield Trust
		106,213performance share rights
Current registered holder(s):		David Banfield, Joy Banfield and Julian Donald astrustees for the David and JoyBanfield Trust
Registered holder(s)once transfers are registered:		David Banfield
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		3
Details of transactions requiring disclosure-
Date of transaction:		31-Aug-21
		16,331 shares and 70,719 performance share
		rights issued under the Comvita Limited
Nature of transaction:		Performance Share Rights Scheme
Name of anyotherpartyorparties to the transaction(if known):		Comvita Limited
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value,describe the consideration:		Nil
		16,331 ordinary shares
Number of financialproducts to which the transaction related:		70,719 performance share rights
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:		No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Date of theprior written clearance(if any):
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:
Nature of relevant interest:
_For that relevant interest,- _
Number held in class:
Current registered holder(s):
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:		1/9/2021	08:29 NZST